Phlow

Phlow company information, Employees & Contact Information

Explore related pages

Related company profiles:

Phlow, a B Corporation™, helps brilliant minds bring medicines to life through advanced development and manufacturing in America. Focused on innovations in drug substance development, Phlow supports government and private industry customers to create innovative approaches with scientific expertise, world-class manufacturing, and tech-enabled processes that propel the industry forward to a new standard as we create the future of how medicines are made. As a modern contract development and manufacturing provider, we measure our impact by increasing speed to market, reducing waste, and offering an environmentally friendly approach to manufacturing medicines that lead to healthy, resilient communities. For more, visit phlow-usa.com.

Company Details

Employees
106
Founded
-
Address
424 Hull St,
Phone
804.207.4893
Email
in****@****usa.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Richmond, Virginia
Looking for a particular Phlow employee's phone or email?

Phlow Questions

News

Phlow Appoints Tim Mayleben as Chairman of the Board - citybiz

Phlow Appoints Tim Mayleben as Chairman of the Board citybiz

HHS leaders visit Phlow Corp. campus to see pharmaceuticals made from start to finish - American Hospital Association

HHS leaders visit Phlow Corp. campus to see pharmaceuticals made from start to finish American Hospital Association

Phlow Announces Close of $37M Series C Financing to Accelerate Modern Medicine Development and Manufacturing in America - Yahoo Finance

Phlow Announces Close of $37M Series C Financing to Accelerate Modern Medicine Development and Manufacturing in America Yahoo Finance

Inside the FDA’s New Voucher Program: First 9 Picks Target Diabetes to Vaping - HCPLive

Inside the FDA’s New Voucher Program: First 9 Picks Target Diabetes to Vaping HCPLive

Phlow Corp. Selected by the U.S. Food and Drug Administration Commissioner’s First-Ever National Priority Voucher Pilot Program to Advance Manufacturing of a Critical Essential Medicine in America - The Manila Times

Phlow Corp. Selected by the U.S. Food and Drug Administration Commissioner’s First-Ever National Priority Voucher Pilot Program to Advance Manufacturing of a Critical Essential Medicine in America The Manila Times

Richmond's Phlow hits milestone for U.S.-manufactured epinephrine - The Business Journals

Richmond's Phlow hits milestone for U.S.-manufactured epinephrine The Business Journals

Phlow Receives $35M in Funding to Improve the U.S. Medicine Supply Chain - Contract Pharma

Phlow Receives $35M in Funding to Improve the U.S. Medicine Supply Chain Contract Pharma

Richmond pharma company Phlow secures $37M capital raise - Richmond BizSense

Richmond pharma company Phlow secures $37M capital raise Richmond BizSense

VCU’s Medicines for All Institute partners with industry to secure the domestic pharmaceutical supply chain - VCU News

VCU’s Medicines for All Institute partners with industry to secure the domestic pharmaceutical supply chain VCU News

US government to grant Phlow Corporation for Covid-19 manufacture - Pharmaceutical Technology

US government to grant Phlow Corporation for Covid-19 manufacture Pharmaceutical Technology

How Pharmaceutical Innovation is Transforming Petersburg - Livability.com

How Pharmaceutical Innovation is Transforming Petersburg Livability.com

Phlow: Civica's new Petersburg-based facility will make Central Virginia a national leader - The Progress Index

Phlow: Civica's new Petersburg-based facility will make Central Virginia a national leader The Progress Index

Synthesis of Chiral 1,2-Amino Alcohol-Containing Compounds Utilizing Ruthenium-Catalyzed Asymmetric Transfer Hydrogenation of Unprotected α-Ketoamines | The Journal of Organic Chemistry - ACS Publications

Synthesis of Chiral 1,2-Amino Alcohol-Containing Compounds Utilizing Ruthenium-Catalyzed Asymmetric Transfer Hydrogenation of Unprotected α-Ketoamines | The Journal of Organic Chemistry ACS Publications

Trump to Tap New Company to Make Covid-19 Drugs in the U.S. (Published 2020) - The New York Times

Trump to Tap New Company to Make Covid-19 Drugs in the U.S. (Published 2020) The New York Times

U.S. Government and Phlow Corp. Partner to Build Stockpile of APIs and Other Key Drug Ingredients - BioSpace

U.S. Government and Phlow Corp. Partner to Build Stockpile of APIs and Other Key Drug Ingredients BioSpace

Trump takes a first step toward returning medical supply chains to the U.S. - The Washington Post

Trump takes a first step toward returning medical supply chains to the U.S. The Washington Post

The unfulfilled dream of drug reshoring - Chemical & Engineering News

The unfulfilled dream of drug reshoring Chemical & Engineering News

Trump backed a start-up to make drug ingredients on U.S. soil. Its new products rely on foreign supplies. - The Washington Post

Trump backed a start-up to make drug ingredients on U.S. soil. Its new products rely on foreign supplies. The Washington Post

Bringing drug production back to the US - Chemical & Engineering News

Bringing drug production back to the US Chemical & Engineering News

Trump administration signs up new company to make COVID-19 drugs in U.S. - Reuters

Trump administration signs up new company to make COVID-19 drugs in U.S. Reuters

Top Phlow Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant